Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Natural anti-HIV agent disclosed by Hoechst

Dec. 16, 1997

Peptimmune acquires option for HIV vaccine-related technology from MGH

Dec. 15, 1997

Ligand reports positive results from U.S. pivotal phase III trial of Panretin Gel

Dec. 12, 1997

Alferon N Injection completes phase III in HIV

Dec. 12, 1997

Immune Response recommended to continue Remune phase III trial

Dec. 12, 1997

Cel-Sci AIDS vaccine effective in mouse model of HIV and immunogenic in humans

Dec. 11, 1997

Antisense AIDS therapy from Novopharm Biotech enters clinical trials

Dec. 10, 1997

HBY-097 + lamivudine highly effective against HIV-1 replication in vitro

Dec. 10, 1997

Adefovir dipivoxil now available in expanded access program

Dec. 9, 1997

PMPA prodrug with favorable biological/pharmaceutical properties

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...